This inventor holds 2 USPTO granted patents. Top assignee: Vernalis Research Limited. Active years: 2002-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Wokingham, GB (2002)
- Wiltshire, GB (2004)
Company Filing History:
Years Active: 2002-2004
Title: David Bebbington: Innovator in Pharmaceutical Research
Introduction
David Bebbington is a notable inventor based in Wiltshire, GB. He has made significant contributions to the field of pharmaceutical research, particularly in the development of novel compounds. With a total of 2 patents to his name, Bebbington's work focuses on advancing medical science through innovative solutions.
Latest Patents
Among his latest patents are "Thieno- and furopyrimidine derivatives as A2A-receptor antagonists" and "Indoline derivatives as 5-HT2B and or 5-HTC receptor ligands." These patents reflect his commitment to exploring new therapeutic avenues and enhancing treatment options for various conditions.
Career Highlights
David Bebbington is currently employed at Vernalis Research Limited, where he continues to push the boundaries of pharmaceutical innovation. His work at Vernalis has positioned him as a key player in the research and development of new drugs.
Collaborations
Throughout his career, Bebbington has collaborated with talented individuals such as Claire Elizabeth Dawson and Suneel Gaur. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.
Conclusion
David Bebbington's contributions to pharmaceutical research and his innovative patents underscore his role as a leading inventor in the field. His ongoing work promises to impact the future of medicine significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile